In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients

被引:0
|
作者
Tomasz Olszak
Paulina Zarnowiec
Wieslaw Kaca
Katarzyna Danis-Wlodarczyk
Daria Augustyniak
Pavel Drevinek
Anthony de Soyza
Siobhán McClean
Zuzanna Drulis-Kawa
机构
[1] University of Wroclaw,Institute of Genetics and Microbiology
[2] The Jan Kochanowski University,Division of Gene Technology
[3] Catholic University of Leuven,Department of Medical Microbiology, University Hospital Motol and 2nd Faculty of Medicine
[4] Charles University,Institute of Cellular Medicine, Medical School
[5] Newcastle University,Centre of Microbial Host Interactions
[6] Institute of Technology Tallaght,undefined
来源
关键词
bacteriophages; Phage treatment; Cystic fibrosis; model;
D O I
暂无
中图分类号
学科分类号
摘要
The goal of the study was to determine the relationship between in vitro/in vivo efficacy of environmental Pseudomonas phages and certain phenotypical properties of Pseudomonas aeruginosa (PA) strains. We studied the diversity between particular isolates and determined phage sensitivity in vitro and in vivo in the Galleria mellonella insect model. Twenty-eight lytic bacteriophages specific for PA were tested against 121 CF PA isolates including 29 mucoid PA strains. Most strains from cystic fibrosis (CF) patients were lysed by at least three phages (93.6 %), but completely insensitive strains were also present (6.4 %). Two phages PA5oct and KT28 exhibited high rates of lytic potency on 55–68 % of PA strains (72–86 % of mucoid isolates). We further explored phage activity against six PA strains (CF and non-CF) in vitro, comparing clonal differences in phage susceptibility with bacterial properties such as the ability to form biofilms, mucosity, twitching motility, and biochemical profiles. We observed the relationship between variation in phage susceptibility and Fourier transform infrared spectroscopy (FTIR) analysis in the spectra window of carbohydrates. The protective efficacy of two selected phages against PA PAO1 and 0038 infection was confirmed in vivo in G. mellonella larvae. Generally, the wax moth model results confirmed the data from in vitro assays, but in massive infection of CF isolates, the application of lytic phages probably led to the release of toxic compound causing an increase in larvae mortality. We assumed that apart of in vitro phage activity testing, a simple and convenient wax moth larvae model should be applied for the evaluation of in vivo effectiveness of particular phage preparations.
引用
收藏
页码:6021 / 6033
页数:12
相关论文
共 50 条
  • [1] In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients
    Olszak, Tomasz
    Zarnowiec, Paulina
    Kaca, Wieslaw
    Danis-Wlodarczyk, Katarzyna
    Augustyniak, Daria
    Drevinek, Pavel
    de Soyza, Anthony
    McClean, Siobhan
    Drulis-Kawa, Zuzanna
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2015, 99 (14) : 6021 - 6033
  • [2] The Susceptibility of Pseudomonas aeruginosa Strains from Cystic Fibrosis Patients to Bacteriophages
    Essoh, Christiane
    Blouin, Yann
    Loukou, Guillaume
    Cablanmian, Arsher
    Lathro, Serge
    Kutter, Elizabeth
    Hoang Vu Thien
    Vergnaud, Gilles
    Pourcel, Christine
    PLOS ONE, 2013, 8 (04):
  • [3] In vitro activity of cefiderocol against Pseudomonas aeruginosa isolated from cystic fibrosis patients
    Monogue, Marguerite L.
    Desai, Dhara
    Pybus, Christine A.
    Sanders, James M.
    Clark, Andrew E.
    Greenberg, David E.
    MICROBIOLOGY SPECTRUM, 2023, 11 (06):
  • [4] Synergistic Activity of Berberine with Azithromycin against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung In Vitro and In Vivo
    Li, YongTao
    Huang, JianRong
    Li, LanJuan
    Liu, LinSheng
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 42 (04) : 1657 - 1669
  • [5] In Vitro Newly Isolated Environmental Phage Activity against Biofilms Preformed by Pseudomonas aeruginosa from Patients with Cystic Fibrosis
    Fiscarelli, Ersilia Vita
    Rossitto, Martina
    Rosati, Paola
    Essa, Nour
    Crocetta, Valentina
    Di Giulio, Andrea
    Lupetti, Veronica
    Di Bonaventura, Giovanni
    Pompilio, Arianna
    MICROORGANISMS, 2021, 9 (03) : 1 - 19
  • [6] In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolated from patients with cystic fibrosis
    Ruiz, Victor H.
    Fratoni, Andrew
    Nicolau, David P.
    Kuti, Joseph L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023,
  • [7] Repurposing the Veterinary Antibiotic Apramycin for Antibacterial and Antibiofilm Activity Against Pseudomonas aeruginosa From Cystic Fibrosis Patients
    Di Bonaventura, Giovanni
    Lupetti, Veronica
    Verginelli, Fabio
    Giancristofaro, Sara
    Barbieri, Rosemary
    Gherardi, Giovanni
    Pompilio, Arianna
    FRONTIERS IN MICROBIOLOGY, 2022, 12
  • [8] Cell-free supernatants from Lactobacillus strains exert antibacterial, antibiofilm, and antivirulence activity against Pseudomonas aeruginosa from cystic fibrosis patients
    Pompilio, Arianna
    Kaya, Esingul
    Lupetti, Veronica
    Catelli, Elisa
    Bianchi, Marta
    Maisetta, Giuseppantonio
    Esin, Semih
    Di Bonaventura, Giovanni
    Batoni, Giovanna
    MICROBES AND INFECTION, 2024, 26 (04)
  • [9] Rhesus θ-defensin-1 (RTD-1) exhibits in vitro and in vivo activity against cystic fibrosis strains of Pseudomonas aeruginosa
    Beringer, Paul M.
    Bensman, Timothy J.
    Ho, Henry
    Agnello, Melissa
    Denovel, Nicole
    Albert Nguyen
    Wong-Beringer, Annie
    She, Rosemary
    Tran, Dat Q.
    Moskowitz, Samuel M.
    Selsted, Michael E.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (01) : 181 - 188
  • [10] In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients
    Manduru, M
    Mihm, LB
    White, RL
    Friedrich, LV
    Flume, PA
    Bosso, JA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (09) : 2053 - 2056